Page last updated: 2024-08-16

resveratrol and Cutaneous T-Cell Lymphoma

resveratrol has been researched along with Cutaneous T-Cell Lymphoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Choi, J; Daniels, J; Geskin, L; Nihal, M; Rook, AH; Stonesifer, CJ; Wood, GS; Wu, J	1

Other Studies

1 other study(ies) available for resveratrol and Cutaneous T-Cell Lymphoma

Article	Year
Epigenetic Regulation of Apoptosis in Cutaneous T-Cell Lymphoma: Implications for Therapy with Methotrexate, Jak Inhibitors, and Resveratrol. The Journal of investigative dermatology, 2022, Volume: 142, Issue:2 Topics: Acetylation; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Janus Kinase Inhibitors; Lymphoma, T-Cell, Cutaneous; Methotrexate; Protein Processing, Post-Translational; Resveratrol; Skin Neoplasms	2022

Article

Year

Epigenetic Regulation of Apoptosis in Cutaneous T-Cell Lymphoma: Implications for Therapy with Methotrexate, Jak Inhibitors, and Resveratrol.

The Journal of investigative dermatology, 2022, Volume: 142, Issue:2

Topics: Acetylation; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Janus Kinase Inhibitors; Lymphoma, T-Cell, Cutaneous; Methotrexate; Protein Processing, Post-Translational; Resveratrol; Skin Neoplasms

2022